2.08
price down icon5.02%   -0.11
after-market Handel nachbörslich: 2.39 0.31 +14.90%
loading
Schlusskurs vom Vortag:
$2.19
Offen:
$2.16
24-Stunden-Volumen:
20,436
Relative Volume:
0.69
Marktkapitalisierung:
$39.68M
Einnahmen:
$62.71M
Nettoeinkommen (Verlust:
$-10.48M
KGV:
-7.7037
EPS:
-0.27
Netto-Cashflow:
$-13.77M
1W Leistung:
-7.56%
1M Leistung:
-15.45%
6M Leistung:
-61.62%
1J Leistung:
-54.19%
1-Tages-Spanne:
Value
$2.08
$2.17
1-Wochen-Bereich:
Value
$2.08
$2.39
52-Wochen-Spanne:
Value
$2.00
$7.48

Prophase Labs Inc Stock (PRPH) Company Profile

Name
Firmenname
Prophase Labs Inc
Name
Telefon
(215) 345-0919
Name
Adresse
711 STEWART AVE, SUITE 200, NEW YORK, PA
Name
Mitarbeiter
113
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
PRPH's Discussions on Twitter

Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-12-20 Eingeleitet H.C. Wainwright Buy
2021-10-13 Herabstufung Dawson James Buy → Neutral
2021-01-20 Eingeleitet Dawson James Buy

Prophase Labs Inc Aktie (PRPH) Neueste Nachrichten

pulisher
Nov 04, 2024

ProPhase Labs Launches DNA Complete®: Transforming - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

ProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced Ancestry - StockTitan

Nov 04, 2024
pulisher
Oct 22, 2024

ProPhase Labs to Present at the 2024 ThinkEquity Conference - GlobeNewswire

Oct 22, 2024
pulisher
Oct 17, 2024

ProPhase Labs projects significant 2025 earnings - Investing.com

Oct 17, 2024
pulisher
Oct 17, 2024

ProPhase Labs Announces Positive Updates on Strategic - GlobeNewswire

Oct 17, 2024
pulisher
Oct 17, 2024

ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025 - StockTitan

Oct 17, 2024
pulisher
Oct 05, 2024

Down 34% and 57%, Wall Street Says These 2 Stocks Will Gain 230% - MSN

Oct 05, 2024
pulisher
Oct 04, 2024

ProPhase Labs announces change in accounting firm - Investing.com India

Oct 04, 2024
pulisher
Oct 04, 2024

ProPhase Labs announces change in accounting firm By Investing.com - Investing.com South Africa

Oct 04, 2024
pulisher
Sep 29, 2024

* ProPhase Labs, Inc. Announces final results of its tender offer - Reuters

Sep 29, 2024
pulisher
Sep 26, 2024

ProPhase Labs stock hits 52-week low at $2.02 By Investing.com - Investing.com Australia

Sep 26, 2024
pulisher
Sep 26, 2024

ProPhase Labs reports non-compliance with Nasdaq rules By Investing.com - Investing.com South Africa

Sep 26, 2024
pulisher
Sep 26, 2024

ProPhase Labs reports non-compliance with Nasdaq rules - Investing.com India

Sep 26, 2024
pulisher
Sep 26, 2024

ProPhase Labs Seeks Director Amidst Nasdaq Compliance Issue - TipRanks

Sep 26, 2024
pulisher
Sep 24, 2024

Priority Technology (NASDAQ:PRTH) Reaches New 1-Year High After Analyst Upgrade - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Primoris Services Co. (NASDAQ:PRIM) Shares Sold by Paradigm Capital Management Inc. NY - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

PROCEPT BioRobotics Co. (NASDAQ:PRCT) Given Consensus Rating of “Buy” by Analysts - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

Views of Wall Street’s Leading Experts on Proto Labs Inc - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

Tri Locum Partners LP Trims Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

New underwriter set to launch with ex-Hiscox and AIG leader as chief executive - Insurance Times

Sep 23, 2024
pulisher
Sep 23, 2024

Renaissance Technologies LLC Purchases 106,423 Shares of Proto Labs, Inc. (NYSE:PRLB) - Defense World

Sep 23, 2024
pulisher
Sep 21, 2024

Transatlantique Private Wealth LLC Buys Shares of 150,000 PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World

Sep 21, 2024
pulisher
Sep 19, 2024

Progyny Stock Faces Its Biggest Drop Ever After Losing a Major Client. Why These Analysts Like the Stock. - Barron's

Sep 19, 2024
pulisher
Sep 19, 2024

Mark Sheptoff Financial Planning LLC Purchases New Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

Progyny Shares Fall 20% After Announcing It Will Lose 'Significant' Client - MarketWatch

Sep 18, 2024
pulisher
Sep 18, 2024

Priority Technology (NASDAQ:PRTH) Hits New 52-Week High at $6.90 - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Data clang on Street for Prelude but SMARCA2 overtures continue - BioWorld Online

Sep 18, 2024
pulisher
Sep 18, 2024

Procaps Issues Shareholder Letter Update - GlobeNewswire

Sep 18, 2024
pulisher
Sep 17, 2024

Priority Technology (NASDAQ:PRTH) Shares Gap Up to $6.02 - MarketBeat

Sep 17, 2024
pulisher
Sep 17, 2024

Prelude Therapeutics (NASDAQ:PRLD) Receives “Market Outperform” Rating from JMP Securities - Defense World

Sep 17, 2024
pulisher
Sep 11, 2024

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing - Yahoo Finance

Sep 11, 2024
pulisher
Sep 03, 2024

ProPhase Labs, Inc. (NASDAQ:PRPH) Q2 2024 Earnings Call Transcript - MSN

Sep 03, 2024
pulisher
Aug 22, 2024

ProPhase Labs secures $10M in amended note agreement By Investing.com - Investing.com Canada

Aug 22, 2024
pulisher
Aug 22, 2024

ProPhase Labs secures $10M in amended note agreement - Investing.com

Aug 22, 2024
pulisher
Aug 19, 2024

ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event - GlobeNewswire

Aug 19, 2024
pulisher
Aug 19, 2024

ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Acquired by Vanguard Group Inc. - Defense World

Aug 19, 2024
pulisher
Aug 18, 2024

PRPH (ProPhase Labs) Inventory-to-Revenue : 1.54 (As of Jun. 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 16, 2024

PRPH (ProPhase Labs) Ending Cash Position : $2.37 Mil (As of Jun. 2024) - GuruFocus.com

Aug 16, 2024
pulisher
Aug 16, 2024

PRPH (ProPhase Labs) Machinery, Furniture, Equipment : $0.00 Mil (As of Jun. 2024) - GuruFocus.com

Aug 16, 2024
pulisher
Aug 16, 2024

PRPH (ProPhase Labs) Quick Ratio : 1.44 (As of Jun. 2024) - GuruFocus.com

Aug 16, 2024
pulisher
Aug 16, 2024

PRPH (ProPhase Labs) Volatility : 80.80% (As of Aug. 16, 2024) - GuruFocus.com

Aug 16, 2024
pulisher
Aug 15, 2024

PRPH (ProPhase Labs) Net Income From Continuing Operations : $-26.31 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 15, 2024
pulisher
Aug 15, 2024

PRPH (ProPhase Labs) COGS-to-Revenue : 1.19 (As of Jun. 2024) - GuruFocus.com

Aug 15, 2024
pulisher
Aug 15, 2024

ProPhase Labs Inc (PRPH) Q2 2024 Earnings Call Transcript Highli - GuruFocus.com

Aug 15, 2024
pulisher
Aug 15, 2024

ProPhase Labs stock hits 52-week low at $2.31 amid market challenges - Investing.com

Aug 15, 2024
pulisher
Aug 14, 2024

ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2024 - GlobeNewswire

Aug 14, 2024
pulisher
Aug 14, 2024

Earnings call: ProPhase Labs focuses on growth amid seasonal challenges By Investing.com - Investing.com India

Aug 14, 2024
pulisher
Aug 14, 2024

Earnings call: ProPhase Labs focuses on growth amid seasonal challenges - Investing.com

Aug 14, 2024
pulisher
Aug 14, 2024

PRPH Stock Earnings: ProPhase Labs Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace

Aug 14, 2024
pulisher
Aug 14, 2024

ProPhase Labs partners with FHC for cancer test rollout - Investing.com

Aug 14, 2024
pulisher
Aug 13, 2024

ProPhase Labs Q2 2024 Earnings Preview - MSN

Aug 13, 2024

Finanzdaten der Prophase Labs Inc-Aktie (PRPH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$226.42
price up icon 3.48%
diagnostics_research LH
$229.11
price up icon 0.85%
diagnostics_research WAT
$387.17
price down icon 0.04%
$154.96
price up icon 0.96%
diagnostics_research MTD
$1,385.79
price up icon 1.60%
$415.98
price up icon 0.35%
Kapitalisierung:     |  Volumen (24h):